HLA-G expression in Merkel cell carcinoma and the correlation with Merkel cell polyomavirus infection

L M Parra1, B G C Sartori2, D R Fernandes3

  • 1Clinical Laboratory, Amaral Carvalho Hospital-Jaú, Dona Silvéria, 150 - Chácara Braz Miraglia, São Paulo, 17210-070, Brazil. leomparra@gmail.com.

Immunogenetics
|October 13, 2022
PubMed

Insights

Merkel cell carcinoma (MCC) research found Human Leukocyte Antigen-G (HLA-G) expression linked to poorer survival. Merkel cell-associated polyomavirus (MCPyV) was detected in most patients, associated with less sun exposure.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with high mortality.
  • The etiology of MCC is not fully understood, but Merkel cell-associated polyomavirus (MCPyV) is a suspected risk factor.
  • Human Leukocyte Antigen-G (HLA-G), an immunoregulatory molecule, has been implicated in tumor escape but not studied in MCC.

Purpose of the Study:

  • To evaluate HLA-G expression in MCC patients.
  • To detect MCPyV presence in MCC patients.
  • To correlate HLA-G and MCPyV with the clinical course of MCC.

Main Methods:

  • Retrospective study of 45 MCC patients.
  • Immunohistochemistry and RT-PCR on formalin-fixed paraffin-embedded skin biopsies.
  • Analysis of HLA-G expression, MCPyV infection, and clinical data.

Main Results:

  • HLA-G expression was found in 15.6% of patients.
  • MCPyV was detected in 62.2% of patients.
  • MCPyV presence correlated with low sun exposure (p=0.042); HLA-G expression correlated with progression to death (p=0.038). No significant association between HLA-G and MCPyV (p=0.250).

Conclusions:

  • Both HLA-G expression and MCPyV presence were confirmed in MCC patients.
  • HLA-G expression may be a negative prognostic factor impacting patient survival.
  • Further research with larger cohorts is needed to clarify the roles of HLA-G and MCPyV in MCC progression.

Related Concept Videos